Nanoparticle Transfer Through Endothelial Barrier - NanoTENDO
Project summary
The controlled delivery of drugs to the brain remains a challenge in the effective treatment of neurodegenerative diseases due to the role played by the endothelial barrier. The endothelial barrier is an important part of the body. It consists of the layer of the special cells organized in a complex system. This barrier surrounds our vessels and protects the body tissues from unwanted visitors: microbes and toxic substances. However, the fact that this barrier recognizes all substances as intruding species causes a huge medical problem in treatment for many severe brain diseases, among them the Alzheimer disease. Our project aims to develop the nanoformulations based on dendrimers, dendrons or gold nanoparticles which will overcome the endothelial barrier resulting in the effective and specific delivery of therapeutic substances.Project Details
Call
Call 2018
Call Topic
New strategies for advanced material-based technologies in health applications
Project start
01.10.2019
Project end
31.08.2024
Total project costs
600.854 €
Total project funding
600.854 €
TRL
1 - 3
Coordinator
Prof. Maria Bryszewska
maria.bryszewska@biol.uni.lodz.pl
University of Lodz, Department of General Biophysics, Narutowicza 68, 90-136 Lodz, Poland
Partners and Funders Details
Consortium Partner | Country | Funder | |
---|---|---|---|
University of Lodz, Department of General Biophysics https://www.uni.lodz.pl |
University | Poland | PL-NCN |
Universidad de Alcala, Organic and Inorganic Chemistry https://www.uah.es |
University | Spain | No Funding |
Riga Stradins University https://www.rsu.lv |
University | Latvia | LV-VIAA |
Latvian Biomedical Research and Study Centre http://bmc.biomed.lu.lv/en/ |
Research org. | Latvia | LV-VIAA |